-
of data and analytical solutions Lead the evaluation, implementation and deployment of emerging tools and analytic data engineering process in order to improve team productivity BASIC QUALIFICATIONS
-
of the Oncogenic Transcriptional Networks Group within the Cancer Cell Biology (CCB) Department. The candidate should have expertise in cell line engineering technologies, molecular and protein biology methods, and
-
. Develop strategic collaborations with academic and industrial researchers for addressing gaps in fundamental or applied science related to the pharmaceutical sciences Conduct novel research and present
-
PhD in Pharmacometrics, Clinical Pharmacology, Pharmacokinetics, Engineering, Pharmaceutical Sciences, or PharmD Strong written and verbal communication skills PREFERRED QUALIFICATIONS Experience
-
knowledge of Pfizer business divisions and interrelationships between them. Engages in continuous learning; shows commitment to being familiar with new regulations and industry standards, new technology , and
-
development and health technology assessment (HTA). The applicant is expected to develop highly effective collaborations with relevant stakeholders including those in Patient Health & Impact, the Patient
-
of the Oncogenic Transcriptional Networks Group within the Cancer Cell Biology (CCB) Department. The candidate should have expertise in cell line engineering technologies, molecular and protein biology methods, and
-
at country or regional level Responsible for PTA and SIV report review for reports completed by the Site Care Partner Supports implementation of Pfizer's Site Technology Experience systems (e.g. Shared
-
insights Planning and conducting medical analyses Prepare and maintain datasets for on-going analytical needs in collaboration with data engineers Flag data issues to data engineers and advice on required
-
-functional teams via emails, training sessions, and workshops for generative AI initiatives Deliver insights that inform medical AI strategies through scientific exchange, including those from technology/AI